Global Alzheimer Disease Genetic Testing Market Research Report 2024, Forecast to 2032
Report Overview
Alzheimer's disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer's disease, early detection and treatment can help slow the progression of the disease. Genetic testing can be a useful tool in identifying individuals who may be at higher risk of developing Alzheimer's disease.
The global Alzheimer Disease Genetic Testing market size was estimated at USD 112 million in 2023 and is projected to reach USD 512.13 million by 2032, exhibiting a CAGR of 18.40% during the forecast period.
North America Alzheimer Disease Genetic Testing market size was estimated at USD 39.12 million in 2023, at a CAGR of 15.77% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Alzheimer Disease Genetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alzheimer Disease Genetic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alzheimer Disease Genetic Testing market in any manner.
Global Alzheimer Disease Genetic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Mega Genomics
Blueprint Genetics
Generi-Biotech
RxHomeTest
Kashi Labs
23andMe
LabCorp
Empower DX
SolGent
CapitalBio
Genex Diagnostics
Sansure
Market Segmentation (by Type)
Early-Onset Alzheimer Disease
Late-Onset Alzheimer Disease
Market Segmentation (by Application)
Online
Offline
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alzheimer Disease Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Alzheimer Disease Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Alzheimer's disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer's disease, early detection and treatment can help slow the progression of the disease. Genetic testing can be a useful tool in identifying individuals who may be at higher risk of developing Alzheimer's disease.
The global Alzheimer Disease Genetic Testing market size was estimated at USD 112 million in 2023 and is projected to reach USD 512.13 million by 2032, exhibiting a CAGR of 18.40% during the forecast period.
North America Alzheimer Disease Genetic Testing market size was estimated at USD 39.12 million in 2023, at a CAGR of 15.77% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Alzheimer Disease Genetic Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alzheimer Disease Genetic Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alzheimer Disease Genetic Testing market in any manner.
Global Alzheimer Disease Genetic Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Mega Genomics
Blueprint Genetics
Generi-Biotech
RxHomeTest
Kashi Labs
23andMe
LabCorp
Empower DX
SolGent
CapitalBio
Genex Diagnostics
Sansure
Market Segmentation (by Type)
Early-Onset Alzheimer Disease
Late-Onset Alzheimer Disease
Market Segmentation (by Application)
Online
Offline
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Alzheimer Disease Genetic Testing Market
- Overview of the regional outlook of the Alzheimer Disease Genetic Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alzheimer Disease Genetic Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Alzheimer Disease Genetic Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Alzheimer Disease Genetic Testing
1.2 Key Market Segments
1.2.1 Alzheimer Disease Genetic Testing Segment by Type
1.2.2 Alzheimer Disease Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ALZHEIMER DISEASE GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Alzheimer Disease Genetic Testing Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Alzheimer Disease Genetic Testing Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ALZHEIMER DISEASE GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Alzheimer Disease Genetic Testing Sales by Manufacturers (2019-2024)
3.2 Global Alzheimer Disease Genetic Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Alzheimer Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alzheimer Disease Genetic Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alzheimer Disease Genetic Testing Sales Sites, Area Served, Product Type
3.6 Alzheimer Disease Genetic Testing Market Competitive Situation and Trends
3.6.1 Alzheimer Disease Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Alzheimer Disease Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ALZHEIMER DISEASE GENETIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Alzheimer Disease Genetic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ALZHEIMER DISEASE GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ALZHEIMER DISEASE GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alzheimer Disease Genetic Testing Sales Market Share by Type (2019-2024)
6.3 Global Alzheimer Disease Genetic Testing Market Size Market Share by Type (2019-2024)
6.4 Global Alzheimer Disease Genetic Testing Price by Type (2019-2024)
7 ALZHEIMER DISEASE GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alzheimer Disease Genetic Testing Market Sales by Application (2019-2024)
7.3 Global Alzheimer Disease Genetic Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Alzheimer Disease Genetic Testing Sales Growth Rate by Application (2019-2024)
8 ALZHEIMER DISEASE GENETIC TESTING MARKET CONSUMPTION BY REGION
8.1 Global Alzheimer Disease Genetic Testing Sales by Region
8.1.1 Global Alzheimer Disease Genetic Testing Sales by Region
8.1.2 Global Alzheimer Disease Genetic Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Alzheimer Disease Genetic Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Alzheimer Disease Genetic Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Alzheimer Disease Genetic Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Alzheimer Disease Genetic Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Alzheimer Disease Genetic Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ALZHEIMER DISEASE GENETIC TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Alzheimer Disease Genetic Testing by Region (2019-2024)
9.2 Global Alzheimer Disease Genetic Testing Revenue Market Share by Region (2019-2024)
9.3 Global Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Alzheimer Disease Genetic Testing Production
9.4.1 North America Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.4.2 North America Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Alzheimer Disease Genetic Testing Production
9.5.1 Europe Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.5.2 Europe Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Alzheimer Disease Genetic Testing Production (2019-2024)
9.6.1 Japan Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.6.2 Japan Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Alzheimer Disease Genetic Testing Production (2019-2024)
9.7.1 China Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.7.2 China Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Mega Genomics
10.1.1 Mega Genomics Alzheimer Disease Genetic Testing Basic Information
10.1.2 Mega Genomics Alzheimer Disease Genetic Testing Product Overview
10.1.3 Mega Genomics Alzheimer Disease Genetic Testing Product Market Performance
10.1.4 Mega Genomics Business Overview
10.1.5 Mega Genomics Alzheimer Disease Genetic Testing SWOT Analysis
10.1.6 Mega Genomics Recent Developments
10.2 Blueprint Genetics
10.2.1 Blueprint Genetics Alzheimer Disease Genetic Testing Basic Information
10.2.2 Blueprint Genetics Alzheimer Disease Genetic Testing Product Overview
10.2.3 Blueprint Genetics Alzheimer Disease Genetic Testing Product Market Performance
10.2.4 Blueprint Genetics Business Overview
10.2.5 Blueprint Genetics Alzheimer Disease Genetic Testing SWOT Analysis
10.2.6 Blueprint Genetics Recent Developments
10.3 Generi-Biotech
10.3.1 Generi-Biotech Alzheimer Disease Genetic Testing Basic Information
10.3.2 Generi-Biotech Alzheimer Disease Genetic Testing Product Overview
10.3.3 Generi-Biotech Alzheimer Disease Genetic Testing Product Market Performance
10.3.4 Generi-Biotech Alzheimer Disease Genetic Testing SWOT Analysis
10.3.5 Generi-Biotech Business Overview
10.3.6 Generi-Biotech Recent Developments
10.4 RxHomeTest
10.4.1 RxHomeTest Alzheimer Disease Genetic Testing Basic Information
10.4.2 RxHomeTest Alzheimer Disease Genetic Testing Product Overview
10.4.3 RxHomeTest Alzheimer Disease Genetic Testing Product Market Performance
10.4.4 RxHomeTest Business Overview
10.4.5 RxHomeTest Recent Developments
10.5 Kashi Labs
10.5.1 Kashi Labs Alzheimer Disease Genetic Testing Basic Information
10.5.2 Kashi Labs Alzheimer Disease Genetic Testing Product Overview
10.5.3 Kashi Labs Alzheimer Disease Genetic Testing Product Market Performance
10.5.4 Kashi Labs Business Overview
10.5.5 Kashi Labs Recent Developments
10.6 23andMe
10.6.1 23andMe Alzheimer Disease Genetic Testing Basic Information
10.6.2 23andMe Alzheimer Disease Genetic Testing Product Overview
10.6.3 23andMe Alzheimer Disease Genetic Testing Product Market Performance
10.6.4 23andMe Business Overview
10.6.5 23andMe Recent Developments
10.7 LabCorp
10.7.1 LabCorp Alzheimer Disease Genetic Testing Basic Information
10.7.2 LabCorp Alzheimer Disease Genetic Testing Product Overview
10.7.3 LabCorp Alzheimer Disease Genetic Testing Product Market Performance
10.7.4 LabCorp Business Overview
10.7.5 LabCorp Recent Developments
10.8 Empower DX
10.8.1 Empower DX Alzheimer Disease Genetic Testing Basic Information
10.8.2 Empower DX Alzheimer Disease Genetic Testing Product Overview
10.8.3 Empower DX Alzheimer Disease Genetic Testing Product Market Performance
10.8.4 Empower DX Business Overview
10.8.5 Empower DX Recent Developments
10.9 SolGent
10.9.1 SolGent Alzheimer Disease Genetic Testing Basic Information
10.9.2 SolGent Alzheimer Disease Genetic Testing Product Overview
10.9.3 SolGent Alzheimer Disease Genetic Testing Product Market Performance
10.9.4 SolGent Business Overview
10.9.5 SolGent Recent Developments
10.10 CapitalBio
10.10.1 CapitalBio Alzheimer Disease Genetic Testing Basic Information
10.10.2 CapitalBio Alzheimer Disease Genetic Testing Product Overview
10.10.3 CapitalBio Alzheimer Disease Genetic Testing Product Market Performance
10.10.4 CapitalBio Business Overview
10.10.5 CapitalBio Recent Developments
10.11 Genex Diagnostics
10.11.1 Genex Diagnostics Alzheimer Disease Genetic Testing Basic Information
10.11.2 Genex Diagnostics Alzheimer Disease Genetic Testing Product Overview
10.11.3 Genex Diagnostics Alzheimer Disease Genetic Testing Product Market Performance
10.11.4 Genex Diagnostics Business Overview
10.11.5 Genex Diagnostics Recent Developments
10.12 Sansure
10.12.1 Sansure Alzheimer Disease Genetic Testing Basic Information
10.12.2 Sansure Alzheimer Disease Genetic Testing Product Overview
10.12.3 Sansure Alzheimer Disease Genetic Testing Product Market Performance
10.12.4 Sansure Business Overview
10.12.5 Sansure Recent Developments
11 ALZHEIMER DISEASE GENETIC TESTING MARKET FORECAST BY REGION
11.1 Global Alzheimer Disease Genetic Testing Market Size Forecast
11.2 Global Alzheimer Disease Genetic Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Alzheimer Disease Genetic Testing Market Size Forecast by Country
11.2.3 Asia Pacific Alzheimer Disease Genetic Testing Market Size Forecast by Region
11.2.4 South America Alzheimer Disease Genetic Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Alzheimer Disease Genetic Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Alzheimer Disease Genetic Testing Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Alzheimer Disease Genetic Testing by Type (2025-2032)
12.1.2 Global Alzheimer Disease Genetic Testing Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Alzheimer Disease Genetic Testing by Type (2025-2032)
12.2 Global Alzheimer Disease Genetic Testing Market Forecast by Application (2025-2032)
12.2.1 Global Alzheimer Disease Genetic Testing Sales (K Units) Forecast by Application
12.2.2 Global Alzheimer Disease Genetic Testing Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Alzheimer Disease Genetic Testing
1.2 Key Market Segments
1.2.1 Alzheimer Disease Genetic Testing Segment by Type
1.2.2 Alzheimer Disease Genetic Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ALZHEIMER DISEASE GENETIC TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Alzheimer Disease Genetic Testing Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Alzheimer Disease Genetic Testing Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ALZHEIMER DISEASE GENETIC TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Alzheimer Disease Genetic Testing Sales by Manufacturers (2019-2024)
3.2 Global Alzheimer Disease Genetic Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Alzheimer Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Alzheimer Disease Genetic Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Alzheimer Disease Genetic Testing Sales Sites, Area Served, Product Type
3.6 Alzheimer Disease Genetic Testing Market Competitive Situation and Trends
3.6.1 Alzheimer Disease Genetic Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Alzheimer Disease Genetic Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ALZHEIMER DISEASE GENETIC TESTING INDUSTRY CHAIN ANALYSIS
4.1 Alzheimer Disease Genetic Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ALZHEIMER DISEASE GENETIC TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ALZHEIMER DISEASE GENETIC TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alzheimer Disease Genetic Testing Sales Market Share by Type (2019-2024)
6.3 Global Alzheimer Disease Genetic Testing Market Size Market Share by Type (2019-2024)
6.4 Global Alzheimer Disease Genetic Testing Price by Type (2019-2024)
7 ALZHEIMER DISEASE GENETIC TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alzheimer Disease Genetic Testing Market Sales by Application (2019-2024)
7.3 Global Alzheimer Disease Genetic Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Alzheimer Disease Genetic Testing Sales Growth Rate by Application (2019-2024)
8 ALZHEIMER DISEASE GENETIC TESTING MARKET CONSUMPTION BY REGION
8.1 Global Alzheimer Disease Genetic Testing Sales by Region
8.1.1 Global Alzheimer Disease Genetic Testing Sales by Region
8.1.2 Global Alzheimer Disease Genetic Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Alzheimer Disease Genetic Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Alzheimer Disease Genetic Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Alzheimer Disease Genetic Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Alzheimer Disease Genetic Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Alzheimer Disease Genetic Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ALZHEIMER DISEASE GENETIC TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Alzheimer Disease Genetic Testing by Region (2019-2024)
9.2 Global Alzheimer Disease Genetic Testing Revenue Market Share by Region (2019-2024)
9.3 Global Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Alzheimer Disease Genetic Testing Production
9.4.1 North America Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.4.2 North America Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Alzheimer Disease Genetic Testing Production
9.5.1 Europe Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.5.2 Europe Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Alzheimer Disease Genetic Testing Production (2019-2024)
9.6.1 Japan Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.6.2 Japan Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Alzheimer Disease Genetic Testing Production (2019-2024)
9.7.1 China Alzheimer Disease Genetic Testing Production Growth Rate (2019-2024)
9.7.2 China Alzheimer Disease Genetic Testing Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Mega Genomics
10.1.1 Mega Genomics Alzheimer Disease Genetic Testing Basic Information
10.1.2 Mega Genomics Alzheimer Disease Genetic Testing Product Overview
10.1.3 Mega Genomics Alzheimer Disease Genetic Testing Product Market Performance
10.1.4 Mega Genomics Business Overview
10.1.5 Mega Genomics Alzheimer Disease Genetic Testing SWOT Analysis
10.1.6 Mega Genomics Recent Developments
10.2 Blueprint Genetics
10.2.1 Blueprint Genetics Alzheimer Disease Genetic Testing Basic Information
10.2.2 Blueprint Genetics Alzheimer Disease Genetic Testing Product Overview
10.2.3 Blueprint Genetics Alzheimer Disease Genetic Testing Product Market Performance
10.2.4 Blueprint Genetics Business Overview
10.2.5 Blueprint Genetics Alzheimer Disease Genetic Testing SWOT Analysis
10.2.6 Blueprint Genetics Recent Developments
10.3 Generi-Biotech
10.3.1 Generi-Biotech Alzheimer Disease Genetic Testing Basic Information
10.3.2 Generi-Biotech Alzheimer Disease Genetic Testing Product Overview
10.3.3 Generi-Biotech Alzheimer Disease Genetic Testing Product Market Performance
10.3.4 Generi-Biotech Alzheimer Disease Genetic Testing SWOT Analysis
10.3.5 Generi-Biotech Business Overview
10.3.6 Generi-Biotech Recent Developments
10.4 RxHomeTest
10.4.1 RxHomeTest Alzheimer Disease Genetic Testing Basic Information
10.4.2 RxHomeTest Alzheimer Disease Genetic Testing Product Overview
10.4.3 RxHomeTest Alzheimer Disease Genetic Testing Product Market Performance
10.4.4 RxHomeTest Business Overview
10.4.5 RxHomeTest Recent Developments
10.5 Kashi Labs
10.5.1 Kashi Labs Alzheimer Disease Genetic Testing Basic Information
10.5.2 Kashi Labs Alzheimer Disease Genetic Testing Product Overview
10.5.3 Kashi Labs Alzheimer Disease Genetic Testing Product Market Performance
10.5.4 Kashi Labs Business Overview
10.5.5 Kashi Labs Recent Developments
10.6 23andMe
10.6.1 23andMe Alzheimer Disease Genetic Testing Basic Information
10.6.2 23andMe Alzheimer Disease Genetic Testing Product Overview
10.6.3 23andMe Alzheimer Disease Genetic Testing Product Market Performance
10.6.4 23andMe Business Overview
10.6.5 23andMe Recent Developments
10.7 LabCorp
10.7.1 LabCorp Alzheimer Disease Genetic Testing Basic Information
10.7.2 LabCorp Alzheimer Disease Genetic Testing Product Overview
10.7.3 LabCorp Alzheimer Disease Genetic Testing Product Market Performance
10.7.4 LabCorp Business Overview
10.7.5 LabCorp Recent Developments
10.8 Empower DX
10.8.1 Empower DX Alzheimer Disease Genetic Testing Basic Information
10.8.2 Empower DX Alzheimer Disease Genetic Testing Product Overview
10.8.3 Empower DX Alzheimer Disease Genetic Testing Product Market Performance
10.8.4 Empower DX Business Overview
10.8.5 Empower DX Recent Developments
10.9 SolGent
10.9.1 SolGent Alzheimer Disease Genetic Testing Basic Information
10.9.2 SolGent Alzheimer Disease Genetic Testing Product Overview
10.9.3 SolGent Alzheimer Disease Genetic Testing Product Market Performance
10.9.4 SolGent Business Overview
10.9.5 SolGent Recent Developments
10.10 CapitalBio
10.10.1 CapitalBio Alzheimer Disease Genetic Testing Basic Information
10.10.2 CapitalBio Alzheimer Disease Genetic Testing Product Overview
10.10.3 CapitalBio Alzheimer Disease Genetic Testing Product Market Performance
10.10.4 CapitalBio Business Overview
10.10.5 CapitalBio Recent Developments
10.11 Genex Diagnostics
10.11.1 Genex Diagnostics Alzheimer Disease Genetic Testing Basic Information
10.11.2 Genex Diagnostics Alzheimer Disease Genetic Testing Product Overview
10.11.3 Genex Diagnostics Alzheimer Disease Genetic Testing Product Market Performance
10.11.4 Genex Diagnostics Business Overview
10.11.5 Genex Diagnostics Recent Developments
10.12 Sansure
10.12.1 Sansure Alzheimer Disease Genetic Testing Basic Information
10.12.2 Sansure Alzheimer Disease Genetic Testing Product Overview
10.12.3 Sansure Alzheimer Disease Genetic Testing Product Market Performance
10.12.4 Sansure Business Overview
10.12.5 Sansure Recent Developments
11 ALZHEIMER DISEASE GENETIC TESTING MARKET FORECAST BY REGION
11.1 Global Alzheimer Disease Genetic Testing Market Size Forecast
11.2 Global Alzheimer Disease Genetic Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Alzheimer Disease Genetic Testing Market Size Forecast by Country
11.2.3 Asia Pacific Alzheimer Disease Genetic Testing Market Size Forecast by Region
11.2.4 South America Alzheimer Disease Genetic Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Alzheimer Disease Genetic Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Alzheimer Disease Genetic Testing Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Alzheimer Disease Genetic Testing by Type (2025-2032)
12.1.2 Global Alzheimer Disease Genetic Testing Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Alzheimer Disease Genetic Testing by Type (2025-2032)
12.2 Global Alzheimer Disease Genetic Testing Market Forecast by Application (2025-2032)
12.2.1 Global Alzheimer Disease Genetic Testing Sales (K Units) Forecast by Application
12.2.2 Global Alzheimer Disease Genetic Testing Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Alzheimer Disease Genetic Testing Market Size Comparison by Region (M USD)
Table 5. Global Alzheimer Disease Genetic Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Alzheimer Disease Genetic Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Alzheimer Disease Genetic Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Alzheimer Disease Genetic Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Disease Genetic Testing as of 2022)
Table 10. Global Market Alzheimer Disease Genetic Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Alzheimer Disease Genetic Testing Sales Sites and Area Served
Table 12. Manufacturers Alzheimer Disease Genetic Testing Product Type
Table 13. Global Alzheimer Disease Genetic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Alzheimer Disease Genetic Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Alzheimer Disease Genetic Testing Market Challenges
Table 22. Global Alzheimer Disease Genetic Testing Sales by Type (K Units)
Table 23. Global Alzheimer Disease Genetic Testing Market Size by Type (M USD)
Table 24. Global Alzheimer Disease Genetic Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Alzheimer Disease Genetic Testing Sales Market Share by Type (2019-2024)
Table 26. Global Alzheimer Disease Genetic Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Alzheimer Disease Genetic Testing Market Size Share by Type (2019-2024)
Table 28. Global Alzheimer Disease Genetic Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Alzheimer Disease Genetic Testing Sales (K Units) by Application
Table 30. Global Alzheimer Disease Genetic Testing Market Size by Application
Table 31. Global Alzheimer Disease Genetic Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Alzheimer Disease Genetic Testing Sales Market Share by Application (2019-2024)
Table 33. Global Alzheimer Disease Genetic Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Alzheimer Disease Genetic Testing Market Share by Application (2019-2024)
Table 35. Global Alzheimer Disease Genetic Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Alzheimer Disease Genetic Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Alzheimer Disease Genetic Testing Sales Market Share by Region (2019-2024)
Table 38. North America Alzheimer Disease Genetic Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Alzheimer Disease Genetic Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Alzheimer Disease Genetic Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Alzheimer Disease Genetic Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Alzheimer Disease Genetic Testing Sales by Region (2019-2024) & (K Units)
Table 43. Global Alzheimer Disease Genetic Testing Production (K Units) by Region (2019-2024)
Table 44. Global Alzheimer Disease Genetic Testing Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Alzheimer Disease Genetic Testing Revenue Market Share by Region (2019-2024)
Table 46. Global Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Mega Genomics Alzheimer Disease Genetic Testing Basic Information
Table 52. Mega Genomics Alzheimer Disease Genetic Testing Product Overview
Table 53. Mega Genomics Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Mega Genomics Business Overview
Table 55. Mega Genomics Alzheimer Disease Genetic Testing SWOT Analysis
Table 56. Mega Genomics Recent Developments
Table 57. Blueprint Genetics Alzheimer Disease Genetic Testing Basic Information
Table 58. Blueprint Genetics Alzheimer Disease Genetic Testing Product Overview
Table 59. Blueprint Genetics Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Blueprint Genetics Business Overview
Table 61. Blueprint Genetics Alzheimer Disease Genetic Testing SWOT Analysis
Table 62. Blueprint Genetics Recent Developments
Table 63. Generi-Biotech Alzheimer Disease Genetic Testing Basic Information
Table 64. Generi-Biotech Alzheimer Disease Genetic Testing Product Overview
Table 65. Generi-Biotech Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Generi-Biotech Alzheimer Disease Genetic Testing SWOT Analysis
Table 67. Generi-Biotech Business Overview
Table 68. Generi-Biotech Recent Developments
Table 69. RxHomeTest Alzheimer Disease Genetic Testing Basic Information
Table 70. RxHomeTest Alzheimer Disease Genetic Testing Product Overview
Table 71. RxHomeTest Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. RxHomeTest Business Overview
Table 73. RxHomeTest Recent Developments
Table 74. Kashi Labs Alzheimer Disease Genetic Testing Basic Information
Table 75. Kashi Labs Alzheimer Disease Genetic Testing Product Overview
Table 76. Kashi Labs Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Kashi Labs Business Overview
Table 78. Kashi Labs Recent Developments
Table 79. 23andMe Alzheimer Disease Genetic Testing Basic Information
Table 80. 23andMe Alzheimer Disease Genetic Testing Product Overview
Table 81. 23andMe Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. 23andMe Business Overview
Table 83. 23andMe Recent Developments
Table 84. LabCorp Alzheimer Disease Genetic Testing Basic Information
Table 85. LabCorp Alzheimer Disease Genetic Testing Product Overview
Table 86. LabCorp Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. LabCorp Business Overview
Table 88. LabCorp Recent Developments
Table 89. Empower DX Alzheimer Disease Genetic Testing Basic Information
Table 90. Empower DX Alzheimer Disease Genetic Testing Product Overview
Table 91. Empower DX Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Empower DX Business Overview
Table 93. Empower DX Recent Developments
Table 94. SolGent Alzheimer Disease Genetic Testing Basic Information
Table 95. SolGent Alzheimer Disease Genetic Testing Product Overview
Table 96. SolGent Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. SolGent Business Overview
Table 98. SolGent Recent Developments
Table 99. CapitalBio Alzheimer Disease Genetic Testing Basic Information
Table 100. CapitalBio Alzheimer Disease Genetic Testing Product Overview
Table 101. CapitalBio Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. CapitalBio Business Overview
Table 103. CapitalBio Recent Developments
Table 104. Genex Diagnostics Alzheimer Disease Genetic Testing Basic Information
Table 105. Genex Diagnostics Alzheimer Disease Genetic Testing Product Overview
Table 106. Genex Diagnostics Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Genex Diagnostics Business Overview
Table 108. Genex Diagnostics Recent Developments
Table 109. Sansure Alzheimer Disease Genetic Testing Basic Information
Table 110. Sansure Alzheimer Disease Genetic Testing Product Overview
Table 111. Sansure Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Sansure Business Overview
Table 113. Sansure Recent Developments
Table 114. Global Alzheimer Disease Genetic Testing Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Alzheimer Disease Genetic Testing Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Alzheimer Disease Genetic Testing Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Alzheimer Disease Genetic Testing Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Alzheimer Disease Genetic Testing Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Alzheimer Disease Genetic Testing Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Alzheimer Disease Genetic Testing Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Alzheimer Disease Genetic Testing Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Alzheimer Disease Genetic Testing Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Alzheimer Disease Genetic Testing Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Alzheimer Disease Genetic Testing Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Alzheimer Disease Genetic Testing Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Alzheimer Disease Genetic Testing Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Alzheimer Disease Genetic Testing Market Size Comparison by Region (M USD)
Table 5. Global Alzheimer Disease Genetic Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Alzheimer Disease Genetic Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Alzheimer Disease Genetic Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Alzheimer Disease Genetic Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer Disease Genetic Testing as of 2022)
Table 10. Global Market Alzheimer Disease Genetic Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Alzheimer Disease Genetic Testing Sales Sites and Area Served
Table 12. Manufacturers Alzheimer Disease Genetic Testing Product Type
Table 13. Global Alzheimer Disease Genetic Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Alzheimer Disease Genetic Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Alzheimer Disease Genetic Testing Market Challenges
Table 22. Global Alzheimer Disease Genetic Testing Sales by Type (K Units)
Table 23. Global Alzheimer Disease Genetic Testing Market Size by Type (M USD)
Table 24. Global Alzheimer Disease Genetic Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Alzheimer Disease Genetic Testing Sales Market Share by Type (2019-2024)
Table 26. Global Alzheimer Disease Genetic Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Alzheimer Disease Genetic Testing Market Size Share by Type (2019-2024)
Table 28. Global Alzheimer Disease Genetic Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Alzheimer Disease Genetic Testing Sales (K Units) by Application
Table 30. Global Alzheimer Disease Genetic Testing Market Size by Application
Table 31. Global Alzheimer Disease Genetic Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Alzheimer Disease Genetic Testing Sales Market Share by Application (2019-2024)
Table 33. Global Alzheimer Disease Genetic Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Alzheimer Disease Genetic Testing Market Share by Application (2019-2024)
Table 35. Global Alzheimer Disease Genetic Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Alzheimer Disease Genetic Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Alzheimer Disease Genetic Testing Sales Market Share by Region (2019-2024)
Table 38. North America Alzheimer Disease Genetic Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Alzheimer Disease Genetic Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Alzheimer Disease Genetic Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Alzheimer Disease Genetic Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Alzheimer Disease Genetic Testing Sales by Region (2019-2024) & (K Units)
Table 43. Global Alzheimer Disease Genetic Testing Production (K Units) by Region (2019-2024)
Table 44. Global Alzheimer Disease Genetic Testing Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Alzheimer Disease Genetic Testing Revenue Market Share by Region (2019-2024)
Table 46. Global Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Alzheimer Disease Genetic Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Mega Genomics Alzheimer Disease Genetic Testing Basic Information
Table 52. Mega Genomics Alzheimer Disease Genetic Testing Product Overview
Table 53. Mega Genomics Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Mega Genomics Business Overview
Table 55. Mega Genomics Alzheimer Disease Genetic Testing SWOT Analysis
Table 56. Mega Genomics Recent Developments
Table 57. Blueprint Genetics Alzheimer Disease Genetic Testing Basic Information
Table 58. Blueprint Genetics Alzheimer Disease Genetic Testing Product Overview
Table 59. Blueprint Genetics Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Blueprint Genetics Business Overview
Table 61. Blueprint Genetics Alzheimer Disease Genetic Testing SWOT Analysis
Table 62. Blueprint Genetics Recent Developments
Table 63. Generi-Biotech Alzheimer Disease Genetic Testing Basic Information
Table 64. Generi-Biotech Alzheimer Disease Genetic Testing Product Overview
Table 65. Generi-Biotech Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Generi-Biotech Alzheimer Disease Genetic Testing SWOT Analysis
Table 67. Generi-Biotech Business Overview
Table 68. Generi-Biotech Recent Developments
Table 69. RxHomeTest Alzheimer Disease Genetic Testing Basic Information
Table 70. RxHomeTest Alzheimer Disease Genetic Testing Product Overview
Table 71. RxHomeTest Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. RxHomeTest Business Overview
Table 73. RxHomeTest Recent Developments
Table 74. Kashi Labs Alzheimer Disease Genetic Testing Basic Information
Table 75. Kashi Labs Alzheimer Disease Genetic Testing Product Overview
Table 76. Kashi Labs Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Kashi Labs Business Overview
Table 78. Kashi Labs Recent Developments
Table 79. 23andMe Alzheimer Disease Genetic Testing Basic Information
Table 80. 23andMe Alzheimer Disease Genetic Testing Product Overview
Table 81. 23andMe Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. 23andMe Business Overview
Table 83. 23andMe Recent Developments
Table 84. LabCorp Alzheimer Disease Genetic Testing Basic Information
Table 85. LabCorp Alzheimer Disease Genetic Testing Product Overview
Table 86. LabCorp Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. LabCorp Business Overview
Table 88. LabCorp Recent Developments
Table 89. Empower DX Alzheimer Disease Genetic Testing Basic Information
Table 90. Empower DX Alzheimer Disease Genetic Testing Product Overview
Table 91. Empower DX Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Empower DX Business Overview
Table 93. Empower DX Recent Developments
Table 94. SolGent Alzheimer Disease Genetic Testing Basic Information
Table 95. SolGent Alzheimer Disease Genetic Testing Product Overview
Table 96. SolGent Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. SolGent Business Overview
Table 98. SolGent Recent Developments
Table 99. CapitalBio Alzheimer Disease Genetic Testing Basic Information
Table 100. CapitalBio Alzheimer Disease Genetic Testing Product Overview
Table 101. CapitalBio Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. CapitalBio Business Overview
Table 103. CapitalBio Recent Developments
Table 104. Genex Diagnostics Alzheimer Disease Genetic Testing Basic Information
Table 105. Genex Diagnostics Alzheimer Disease Genetic Testing Product Overview
Table 106. Genex Diagnostics Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Genex Diagnostics Business Overview
Table 108. Genex Diagnostics Recent Developments
Table 109. Sansure Alzheimer Disease Genetic Testing Basic Information
Table 110. Sansure Alzheimer Disease Genetic Testing Product Overview
Table 111. Sansure Alzheimer Disease Genetic Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Sansure Business Overview
Table 113. Sansure Recent Developments
Table 114. Global Alzheimer Disease Genetic Testing Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Alzheimer Disease Genetic Testing Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Alzheimer Disease Genetic Testing Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Alzheimer Disease Genetic Testing Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Alzheimer Disease Genetic Testing Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Alzheimer Disease Genetic Testing Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Alzheimer Disease Genetic Testing Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Alzheimer Disease Genetic Testing Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Alzheimer Disease Genetic Testing Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Alzheimer Disease Genetic Testing Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Alzheimer Disease Genetic Testing Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Alzheimer Disease Genetic Testing Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Alzheimer Disease Genetic Testing Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Alzheimer Disease Genetic Testing Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Alzheimer Disease Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alzheimer Disease Genetic Testing Market Size (M USD), 2019-2032
Figure 5. Global Alzheimer Disease Genetic Testing Market Size (M USD) (2019-2032)
Figure 6. Global Alzheimer Disease Genetic Testing Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alzheimer Disease Genetic Testing Market Size by Country (M USD)
Figure 11. Alzheimer Disease Genetic Testing Sales Share by Manufacturers in 2023
Figure 12. Global Alzheimer Disease Genetic Testing Revenue Share by Manufacturers in 2023
Figure 13. Alzheimer Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Alzheimer Disease Genetic Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Alzheimer Disease Genetic Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Alzheimer Disease Genetic Testing Market Share by Type
Figure 18. Sales Market Share of Alzheimer Disease Genetic Testing by Type (2019-2024)
Figure 19. Sales Market Share of Alzheimer Disease Genetic Testing by Type in 2023
Figure 20. Market Size Share of Alzheimer Disease Genetic Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Alzheimer Disease Genetic Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Alzheimer Disease Genetic Testing Market Share by Application
Figure 24. Global Alzheimer Disease Genetic Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Alzheimer Disease Genetic Testing Sales Market Share by Application in 2023
Figure 26. Global Alzheimer Disease Genetic Testing Market Share by Application (2019-2024)
Figure 27. Global Alzheimer Disease Genetic Testing Market Share by Application in 2023
Figure 28. Global Alzheimer Disease Genetic Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Alzheimer Disease Genetic Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Alzheimer Disease Genetic Testing Sales Market Share by Country in 2023
Figure 32. U.S. Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Alzheimer Disease Genetic Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Alzheimer Disease Genetic Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Alzheimer Disease Genetic Testing Sales Market Share by Country in 2023
Figure 37. Germany Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Alzheimer Disease Genetic Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Alzheimer Disease Genetic Testing Sales Market Share by Region in 2023
Figure 44. China Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Alzheimer Disease Genetic Testing Sales and Growth Rate (K Units)
Figure 50. South America Alzheimer Disease Genetic Testing Sales Market Share by Country in 2023
Figure 51. Brazil Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Alzheimer Disease Genetic Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Alzheimer Disease Genetic Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Alzheimer Disease Genetic Testing Production Market Share by Region (2019-2024)
Figure 62. North America Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 65. China Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Alzheimer Disease Genetic Testing Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Alzheimer Disease Genetic Testing Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Alzheimer Disease Genetic Testing Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Alzheimer Disease Genetic Testing Market Share Forecast by Type (2025-2032)
Figure 70. Global Alzheimer Disease Genetic Testing Sales Forecast by Application (2025-2032)
Figure 71. Global Alzheimer Disease Genetic Testing Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Alzheimer Disease Genetic Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alzheimer Disease Genetic Testing Market Size (M USD), 2019-2032
Figure 5. Global Alzheimer Disease Genetic Testing Market Size (M USD) (2019-2032)
Figure 6. Global Alzheimer Disease Genetic Testing Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alzheimer Disease Genetic Testing Market Size by Country (M USD)
Figure 11. Alzheimer Disease Genetic Testing Sales Share by Manufacturers in 2023
Figure 12. Global Alzheimer Disease Genetic Testing Revenue Share by Manufacturers in 2023
Figure 13. Alzheimer Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Alzheimer Disease Genetic Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Alzheimer Disease Genetic Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Alzheimer Disease Genetic Testing Market Share by Type
Figure 18. Sales Market Share of Alzheimer Disease Genetic Testing by Type (2019-2024)
Figure 19. Sales Market Share of Alzheimer Disease Genetic Testing by Type in 2023
Figure 20. Market Size Share of Alzheimer Disease Genetic Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Alzheimer Disease Genetic Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Alzheimer Disease Genetic Testing Market Share by Application
Figure 24. Global Alzheimer Disease Genetic Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Alzheimer Disease Genetic Testing Sales Market Share by Application in 2023
Figure 26. Global Alzheimer Disease Genetic Testing Market Share by Application (2019-2024)
Figure 27. Global Alzheimer Disease Genetic Testing Market Share by Application in 2023
Figure 28. Global Alzheimer Disease Genetic Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Alzheimer Disease Genetic Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Alzheimer Disease Genetic Testing Sales Market Share by Country in 2023
Figure 32. U.S. Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Alzheimer Disease Genetic Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Alzheimer Disease Genetic Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Alzheimer Disease Genetic Testing Sales Market Share by Country in 2023
Figure 37. Germany Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Alzheimer Disease Genetic Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Alzheimer Disease Genetic Testing Sales Market Share by Region in 2023
Figure 44. China Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Alzheimer Disease Genetic Testing Sales and Growth Rate (K Units)
Figure 50. South America Alzheimer Disease Genetic Testing Sales Market Share by Country in 2023
Figure 51. Brazil Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Alzheimer Disease Genetic Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Alzheimer Disease Genetic Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Alzheimer Disease Genetic Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Alzheimer Disease Genetic Testing Production Market Share by Region (2019-2024)
Figure 62. North America Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 65. China Alzheimer Disease Genetic Testing Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Alzheimer Disease Genetic Testing Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Alzheimer Disease Genetic Testing Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Alzheimer Disease Genetic Testing Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Alzheimer Disease Genetic Testing Market Share Forecast by Type (2025-2032)
Figure 70. Global Alzheimer Disease Genetic Testing Sales Forecast by Application (2025-2032)
Figure 71. Global Alzheimer Disease Genetic Testing Market Share Forecast by Application (2025-2032)
